We publish no single base value for Accenture. Our valuation methods put it between $278.90 and $344.26 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate.
| Method | Value | vs price | Basis |
|---|---|---|---|
| Discounted cash flow | $344.26 | +37.7% | free cash flow $11.62bn, growth 6.2% for 5 years, then fading to 3% over 5 more, discounted at 9.95%; plus net cash $0.63 a share; stress floor $222.93 |
| Exit multiple (P/E) | $278.90 | +11.6% | earnings per share $14.67 valued at 24.19× (the stock's own median P/E) in 5 years, discounted back |
| Sum of the parts | — | — | no sum of the parts: this run holds no segment disclosure for the name |
| Price to sales | — | — | not reached: the cash-flow or earnings methods produced an anchor, so this fallback was not run |
| Tangible book | — | — | used only for lenders, where book value is the business |
| Price to FFO (REITs) | — | — | used only for REITs |
Each working is rebuilt by code from the valuation's own figures and checked against the published value.
The discount rate:
| Risk-free rate | 5.13% (10-year US Treasury yield) |
| Company's own beta | 1.01 (5 years of monthly returns against the S&P 500; standard error 0.31) |
| Peer beta | 1.34 (median of 73 S&P 500 Information Technology companies) |
| Blend of own and peers | 1.10 (72% own, 28% peers, weighted by how precisely the company's own beta is measured) |
| Adjusted beta | 1.07 (0.67 × 1.10 + 0.33, pulled toward the market's 1.0) |
| Equity risk premium | 4.5% |
| Discount rate = risk-free + adjusted beta × premium | 9.95% |
Free cash flow grows 6.20% a year for 5 years, then fades in equal steps toward 3% over 5 more; each year is discounted by 1 ÷ (1 + rate)^year:
| Year | Growth | Free cash flow | Discount factor | Present value |
|---|---|---|---|---|
| Now | — | $11.62bn | — | — |
| Year 1 | 6.20% | $12.34bn | 0.9095 | $11.22bn |
| Year 2 | 6.20% | $13.11bn | 0.8273 | $10.84bn |
| Year 3 | 6.20% | $13.92bn | 0.7524 | $10.47bn |
| Year 4 | 6.20% | $14.78bn | 0.6844 | $10.12bn |
| Year 5 | 6.20% | $15.70bn | 0.6225 | $9.77bn |
| Year 6 | 5.67% | $16.59bn | 0.5662 | $9.39bn |
| Year 7 | 5.13% | $17.44bn | 0.5150 | $8.98bn |
| Year 8 | 4.60% | $18.24bn | 0.4684 | $8.54bn |
| Year 9 | 4.07% | $18.98bn | 0.4260 | $8.09bn |
| Year 10 | 3.53% | $19.65bn | 0.3875 | $7.62bn |
| Terminal value = year-10 cash flow × (1 + 3%) ÷ (9.95% − 3%) | $291.49bn |
| Terminal value in today's money | $112.94bn |
| Present value of years 1–10 | $95.05bn |
| Total present value | $207.99bn |
| Shares outstanding | 605.28m |
| Cash flows per share = total ÷ shares | $343.63 |
| Plus net cash per share | $0.63 |
| Value per share | $344.26 |
How the DCF value moves with the discount rate and the starting growth (the middle cell is the published value):
| Discount rate | Growth 1.2% | Growth 6.2% | Growth 11.2% |
|---|---|---|---|
| 8.95% | $298.84 | $404.13 | $544.48 |
| 9.95% | $256.69 | $344.26 | — |
| 10.95% | $225.12 | $299.54 | — |
The same DCF at each beta, starting growth unchanged:
| Beta | Value | Discount rate | DCF value |
|---|---|---|---|
| Company's own beta | 1.01 | 9.68% | $358.64 |
| Peer beta | 1.34 | 11.16% | $291.36 |
| Adjusted beta (used) | 1.07 | 9.95% | $344.26 |
Earnings per share grow on the same fading path as the DCF:
| Year | Growth | Earnings per share |
|---|---|---|
| Now | — | $14.67 |
| Year 1 | 6.20% | $15.58 |
| Year 2 | 5.24% | $16.40 |
| Year 3 | 4.57% | $17.15 |
| Year 4 | 4.10% | $17.85 |
| Year 5 | 3.77% | $18.52 |
| Earnings per share in year 5 | $18.52 |
| Exit P/E (the stock's own median P/E) | 24.19× |
| Value in 5 years = earnings × P/E | $448.05 |
| Discounted at 9.95% over 5 years: ÷ 1.6065 | $278.90 |
We publish no single base value for Accenture. Our valuation methods put it between $278.90 and $344.26 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate.
One-year price simulation: a 10% chance the price is below $119.29 and a 10% chance it is above $474.96 in a year; a 47% chance it is higher than today's $249.95, from 53.63% volatility. The simulation assumes the price drifts up at our discount rate of 9.95% a year.
At $249.95 the price implies free cash flow growing 0.8% a year for five years and then fading toward 3% over five more; its revenue has grown 6.2%.
| Week | Price | Base value |
|---|---|---|
| 2 Oct 2026 | $198.90 | $281.88 |
| 9 Oct 2026 | $209.06 | $282.35 |
| 16 Oct 2026 | $229.68 | $336.85 |
| 23 Oct 2026 | $249.37 | — |
| 30 Oct 2026 | $258.24 | — |
| 6 Nov 2026 | $260.50 | — |
| 12 Nov 2026 | $249.95 | — |
Data as of 12 Nov 2026; financials to 31 Aug 2026. Sources: company filings via EODHD, SEC EDGAR, US Treasury. How these values are computed. Not investment advice.
Run a full Desk Run on ACN · Accenture company page · Call and put prices